Diatron announces its entry into Indian market

The company plan to commence manufacturing its associated reagents for medical and veterinary use in India from 2024

Diatron has inaugurated a new office in New Delhi, India. This strategic move to provide its services to both existing and new customers in the Asia-Pacific (APAC) region. Additionally, they plan to commence manufacturing their associated reagents for medical and veterinary use in India from 2024.

The establishment of a sales presence in the APAC region to ensure swift and timely support, expediting project progress and leading to more efficient outcomes. Enhanced communication capabilities and geographical proximity promise to eliminate language barriers, fostering a more productive collaboration.

Peter Zsoka, CFO & Board of Director, Diatron MI Plc., Budapest, Hungary, spoke about the Indian expansion project, saying, “We started this journey five years ago with a vision to expand our regional presence. The inauguration of our new office in Delhi marks a significant milestone. With the new office, we plan to further strengthen our commitment to the Indian market. Our goal is to commence reagent manufacturing in India by 2024, reflecting our dedication to this region and the healthcare sector.”

Ronald Backes, Vice President of Sales & Marketing & Board Member, Diatron, Budapest, Hungary, says, “We are dedicated to strengthening our partnership with the Asian market, a region that has always been of the utmost importance to us. The opening of our new office is a testament to our commitment to contributing to healthcare advancements. The early results and benefits we’ve witnessed are just the beginning of a long and prosperous partnership. Together, we aim to spearhead healthcare advancements in Asia, ultimately enhancing the quality of patients’ lives.”

Julio Freyre, Director, Clinical Chemistry Business, Diatron MI Plc. in Budapest, Hungary, expressed, “Expanding into the APAC region is a remarkable stride in our dedication to advancing global healthcare. We are determined to bolster the healthcare system in the region by offering innovative solutions and cutting-edge diagnostics. Our devoted team in India will play a pivotal role in realising this vision.”

 


business expansionDiatroninvestment
Comments (0)
Add Comment